Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Fertility | Study Protocol

Increasing access to fertility preservation for women with breast cancer: protocol for a stepped-wedge cluster randomized trial in France

Authors: Maria Claudia Addamiano, Camille Joannes, Leslie Fonquerne, Charlotte Morel, Delphine Lauzeille, Lorène Belkadi, Fabienne Empereur, Pascale Grosclaude, Eric Bauvin, Cyrille Delpierre, Sébastien Lamy, Marie-Anne Durand

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

With the increase in the number of long-term survivors, interest is shifting from cancer survival to life and quality of life after cancer. These include consequences of long-term side effects of treatment, such as gonadotoxicity. Fertility preservation is becoming increasingly important in cancer management. International recommendations agree on the need to inform patients prior to treatments about the risk of fertility impairment and refer them to specialized centers to discuss fertility preservation. However, the literature reveals suboptimal access to fertility preservation on an international scale, and particularly in France, making information for patients and oncologists a potential lever for action. Our overall goal is to improve access to fertility preservation consultations for women with breast cancer through the development and evaluation of a combined intervention targeting the access and diffusion of information for these patients and brief training for oncologists.

Methods

Firstly, we will improve existing information tools and create brief training content for oncologists using a qualitative, iterative, user-centred and participatory approach (objective 1). We will then use these tools in a combined intervention to conduct a stepped-wedge cluster randomized trial (objective 2) including 750 women aged 18 to 40 newly treated with chemotherapy for breast cancer at one of the 6 participating centers. As the primary outcome of the trial will be the access to fertility preservation counselling before and after using the combined intervention (brochures and brief training for oncologists), we will compare the rate of fertility preservation consultations between the usual care and intervention phases using linear regression models. Finally, we will analyse our approach using a context-sensitive implementation analysis and provide key elements for transferability to other contexts in France (objective 3).

Discussion

We expect to observe an increase in access to fertility preservation consultations as a result of the combined intervention. Particular attention will be paid to the effect of this intervention on socially disadvantaged women, who are known to be at greater risk of inappropriate treatment. The user-centred design principles and participatory approaches used to optimize the acceptability, usability and feasibility of the combined intervention will likely enhance its impact, diffusion and sustainability.

Trial registration

Registry: ClinicalTrials.gov. Trial registration number: NCT05989776. Date of registration: 7th September 2023. URL: https://​classic.​clinicaltrials.​gov/​ct2/​show/​NCT05989776.

Protocol version

Manuscript based on study protocol version 2.0, 21st may 2023.
Appendix
Available only for authorised users
Literature
1.
go back to reference Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet mars. 2018;391(10125):1023–75.CrossRef Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet mars. 2018;391(10125):1023–75.CrossRef
2.
go back to reference Cowppli-Bony A, Colonna M, Ligier K, Jooste V, Defossez G, Monnereau A, et al. Épidémiologie descriptive des cancers en France métropolitaine: incidence, survie et prévalence. Bull Du Cancer Juill. 2019;106(7–8):617–34.CrossRef Cowppli-Bony A, Colonna M, Ligier K, Jooste V, Defossez G, Monnereau A, et al. Épidémiologie descriptive des cancers en France métropolitaine: incidence, survie et prévalence. Bull Du Cancer Juill. 2019;106(7–8):617–34.CrossRef
3.
go back to reference Di Emidio G, D’Aurora M, Placidi M, Franchi S, Rossi G, Stuppia L, et al. Pre-conceptional maternal exposure to cyclophosphamide results in modifications of DNA methylation in F1 and F2 mouse oocytes: evidence for transgenerational effects. Epigenetics 2 nov. 2019;14(11):1057–64.CrossRef Di Emidio G, D’Aurora M, Placidi M, Franchi S, Rossi G, Stuppia L, et al. Pre-conceptional maternal exposure to cyclophosphamide results in modifications of DNA methylation in F1 and F2 mouse oocytes: evidence for transgenerational effects. Epigenetics 2 nov. 2019;14(11):1057–64.CrossRef
4.
go back to reference Hoog-Labouret N, Merlet F. Conséquences des traitements des cancers et préservation de la fertilité: État Des Connaissances et propositions Rapport De l’Institut national Du cancer et de l’Agence de la biomédecine. Oncologie Mai. 2013;15(5):263–70.CrossRef Hoog-Labouret N, Merlet F. Conséquences des traitements des cancers et préservation de la fertilité: État Des Connaissances et propositions Rapport De l’Institut national Du cancer et de l’Agence de la biomédecine. Oncologie Mai. 2013;15(5):263–70.CrossRef
5.
go back to reference Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer 15 mars. 2012;118(6):1710–7. Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer 15 mars. 2012;118(6):1710–7.
6.
go back to reference Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS et al. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. JCO. 1 juill. 2018;36(19):1994–2001. Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS et al. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. JCO. 1 juill. 2018;36(19):1994–2001.
7.
go back to reference Dolmans MM, Lambertini M, Macklon KT, Almeida Santos T, Ruiz-Casado A, Borini A, et al. EUropean REcommendations for female FERtility preservation (EU-REFER): a joint collaboration between oncologists and fertility specialists. Crit Reviews Oncology/Hematology juin. 2019;138:233–40.CrossRef Dolmans MM, Lambertini M, Macklon KT, Almeida Santos T, Ruiz-Casado A, Borini A, et al. EUropean REcommendations for female FERtility preservation (EU-REFER): a joint collaboration between oncologists and fertility specialists. Crit Reviews Oncology/Hematology juin. 2019;138:233–40.CrossRef
8.
go back to reference The ESHRE Guideline Group on Female Fertility Preservation, Anderson RA, Amant F, Braat D, D’Angelo A et al. Chuva de Sousa Lopes SM, oct. ESHRE guideline: female fertility preservation†. Human Reproduction Open. 3 2020;2020(4):hoaa052. The ESHRE Guideline Group on Female Fertility Preservation, Anderson RA, Amant F, Braat D, D’Angelo A et al. Chuva de Sousa Lopes SM, oct. ESHRE guideline: female fertility preservation†. Human Reproduction Open. 3 2020;2020(4):hoaa052.
9.
go back to reference French Public Health. Code Article L2141-11. French Public Health. Code Article L2141-11.
10.
go back to reference Le Bihan-Benjamin C, Hoog-Labouret N, Lefeuvre D, Carré-Pigeon F, Bousquet PJ. Fertility preservation and cancer: how many persons are concerned? Eur J Obstet Gynecol Reproductive Biology juin. 2018;225:232–5.CrossRef Le Bihan-Benjamin C, Hoog-Labouret N, Lefeuvre D, Carré-Pigeon F, Bousquet PJ. Fertility preservation and cancer: how many persons are concerned? Eur J Obstet Gynecol Reproductive Biology juin. 2018;225:232–5.CrossRef
11.
go back to reference French Biomedical Agency. Medical and Scientific Report from the French Biomedical Agency. Saint-Denis La Plaine; 2018. French Biomedical Agency. Medical and Scientific Report from the French Biomedical Agency. Saint-Denis La Plaine; 2018.
12.
go back to reference French Biomedicine Agency. Medical and Scientific Report from the French Biomedical Agency. Saint Denis La Plaine: Agence de la biomédecine; 2014. French Biomedicine Agency. Medical and Scientific Report from the French Biomedical Agency. Saint Denis La Plaine: Agence de la biomédecine; 2014.
13.
go back to reference Bastings L, Baysal O, Beerendonk CCM, IntHout J, Traas MAF, Verhaak CM, et al. Deciding about fertility preservation after specialist counselling. Hum Reprod 1 août. 2014;29(8):1721–9.CrossRef Bastings L, Baysal O, Beerendonk CCM, IntHout J, Traas MAF, Verhaak CM, et al. Deciding about fertility preservation after specialist counselling. Hum Reprod 1 août. 2014;29(8):1721–9.CrossRef
14.
go back to reference Bentsen L, Pappot H, Hjerming M, Hanghøj S. Thoughts about fertility among female adolescents and young adults with cancer: a qualitative study. Support Care Cancer Juill. 2023;31(7):421.CrossRef Bentsen L, Pappot H, Hjerming M, Hanghøj S. Thoughts about fertility among female adolescents and young adults with cancer: a qualitative study. Support Care Cancer Juill. 2023;31(7):421.CrossRef
15.
go back to reference Sallem A, Shore J, Ray-Coquard I, Ferreux L, Bourdon M, Maignien C, et al. Fertility preservation in women with cancer: a national study about French oncologists awareness, experience, and feelings. J Assist Reprod Genet Oct. 2018;35(10):1843–50.CrossRef Sallem A, Shore J, Ray-Coquard I, Ferreux L, Bourdon M, Maignien C, et al. Fertility preservation in women with cancer: a national study about French oncologists awareness, experience, and feelings. J Assist Reprod Genet Oct. 2018;35(10):1843–50.CrossRef
16.
go back to reference Mangiardi-Veltin M, Sebbag C, Rousset-Jablonski C, Ray-Coquard I, Berkach C, Laot L, et al. Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors. Reproductive Biomed Online juin. 2022;44(6):1031–44.CrossRef Mangiardi-Veltin M, Sebbag C, Rousset-Jablonski C, Ray-Coquard I, Berkach C, Laot L, et al. Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors. Reproductive Biomed Online juin. 2022;44(6):1031–44.CrossRef
17.
go back to reference Gosset A, Cohade C, Grosclaude P, Oumsack E, Dalenc F, Montagut M, et al. État Des Lieux régional De l’accès à une consultation d’oncofertilité chez les femmes jeunes ayant un cancer Du Sein. Volume 47. Gynécologie Obstétrique Fertilité & Sénologie; oct 2019. pp. 732–8. 10. Gosset A, Cohade C, Grosclaude P, Oumsack E, Dalenc F, Montagut M, et al. État Des Lieux régional De l’accès à une consultation d’oncofertilité chez les femmes jeunes ayant un cancer Du Sein. Volume 47. Gynécologie Obstétrique Fertilité & Sénologie; oct 2019. pp. 732–8. 10.
18.
go back to reference Martinet-Kosinski F, Lamy S, Bauvin E, Dalenc F, Vaysse C, Grosclaude P. Access to information and oncofertility consultation for young women with breast cancer: a population-based study. Sci Rep 27 févr. 2023;13(1):3313.CrossRef Martinet-Kosinski F, Lamy S, Bauvin E, Dalenc F, Vaysse C, Grosclaude P. Access to information and oncofertility consultation for young women with breast cancer: a population-based study. Sci Rep 27 févr. 2023;13(1):3313.CrossRef
19.
go back to reference Martinet-Kosinski F, Lamy S, Bauvin E, Dalenc F, Vaysse C, Grosclaude P. The stake of informing patients of the risk of hypofertility after chemotherapy for breast cancer. Front Public Health 3 mars. 2023;11:1129198.CrossRef Martinet-Kosinski F, Lamy S, Bauvin E, Dalenc F, Vaysse C, Grosclaude P. The stake of informing patients of the risk of hypofertility after chemotherapy for breast cancer. Front Public Health 3 mars. 2023;11:1129198.CrossRef
20.
go back to reference Speller B, Sissons A, Daly C, Facey M, Kennedy E, Metcalfe K, et al. An evaluation of oncofertility decision support resources among breast cancer patients and health care providers. BMC Health Serv Res déc. 2019;19(1):101.CrossRef Speller B, Sissons A, Daly C, Facey M, Kennedy E, Metcalfe K, et al. An evaluation of oncofertility decision support resources among breast cancer patients and health care providers. BMC Health Serv Res déc. 2019;19(1):101.CrossRef
21.
go back to reference Woodard TL, Hoffman AS, Crocker LC, Holman DA, Hoffman DB, Ma J, et al. Pathways: patient-centred decision counselling for women at risk of cancer-related infertility: a protocol for a comparative effectiveness cluster randomised trial. BMJ Open févr. 2018;8(2):e019994.CrossRef Woodard TL, Hoffman AS, Crocker LC, Holman DA, Hoffman DB, Ma J, et al. Pathways: patient-centred decision counselling for women at risk of cancer-related infertility: a protocol for a comparative effectiveness cluster randomised trial. BMJ Open févr. 2018;8(2):e019994.CrossRef
22.
go back to reference Ehrbar V, Urech C, Rochlitz C, Zanetti Dällenbach R, Moffat R, Stiller R, et al. Randomized controlled trial on the effect of an online decision aid for young female cancer patients regarding fertility preservation. Hum Reprod 29 sept. 2019;34(9):1726–34.CrossRef Ehrbar V, Urech C, Rochlitz C, Zanetti Dällenbach R, Moffat R, Stiller R, et al. Randomized controlled trial on the effect of an online decision aid for young female cancer patients regarding fertility preservation. Hum Reprod 29 sept. 2019;34(9):1726–34.CrossRef
23.
go back to reference Van Den Berg M, Van Der Meij E, Bos AME, Boshuizen MCS, Determann D, Van Eekeren RRJP, et al. Development and testing of a tailored online fertility preservation decision aid for female cancer patients. Cancer Med mars. 2021;10(5):1576–88.CrossRef Van Den Berg M, Van Der Meij E, Bos AME, Boshuizen MCS, Determann D, Van Eekeren RRJP, et al. Development and testing of a tailored online fertility preservation decision aid for female cancer patients. Cancer Med mars. 2021;10(5):1576–88.CrossRef
24.
go back to reference Speller B, Metcalfe K, Kennedy ED, Facey M, Greenblatt E, Scheer AS, et al. The « begin exploring Fertility options, risks and expectations » (BEFORE) decision aid: development and alpha testing of a fertility tool for premenopausal breast cancer patients. BMC Med Inform Decis Mak déc. 2019;19(1):203.CrossRef Speller B, Metcalfe K, Kennedy ED, Facey M, Greenblatt E, Scheer AS, et al. The « begin exploring Fertility options, risks and expectations » (BEFORE) decision aid: development and alpha testing of a fertility tool for premenopausal breast cancer patients. BMC Med Inform Decis Mak déc. 2019;19(1):203.CrossRef
25.
go back to reference Saint-Pierre L, Lamarre MC, Simos J. L’évaluation d’impact sur la santé (EIS): une démarche intersectorielle pour l’action sur les déterminants sociaux, économiques et environnementaux de la santé. Glob Health Promot mars. 2014;21(1suppl):7–14.CrossRef Saint-Pierre L, Lamarre MC, Simos J. L’évaluation d’impact sur la santé (EIS): une démarche intersectorielle pour l’action sur les déterminants sociaux, économiques et environnementaux de la santé. Glob Health Promot mars. 2014;21(1suppl):7–14.CrossRef
26.
go back to reference Villeval M, Gaborit E, Berault F, Lang T, Kelly-Irving M. Do the key functions of an intervention designed from the same specifications vary according to context? Investigating the transferability of a public health intervention in France. Implement Sci déc. 2019;14(1):35.CrossRef Villeval M, Gaborit E, Berault F, Lang T, Kelly-Irving M. Do the key functions of an intervention designed from the same specifications vary according to context? Investigating the transferability of a public health intervention in France. Implement Sci déc. 2019;14(1):35.CrossRef
27.
go back to reference Simmons RA, Cosgrove SC, Romney MC, Plumb JD, Brawer RO, Gonzalez ET, et al. Health literacy: Cancer Prevention Strategies for early adults. Am J Prev Med sept. 2017;53(3S1):73–7.CrossRef Simmons RA, Cosgrove SC, Romney MC, Plumb JD, Brawer RO, Gonzalez ET, et al. Health literacy: Cancer Prevention Strategies for early adults. Am J Prev Med sept. 2017;53(3S1):73–7.CrossRef
28.
go back to reference Durand M, Yen RW, O’Malley AJ, Schubbe D, Politi MC, Saunders CH, et al. What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strata. Cancer févr. 2021;127(3):422–36.CrossRef Durand M, Yen RW, O’Malley AJ, Schubbe D, Politi MC, Saunders CH, et al. What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strata. Cancer févr. 2021;127(3):422–36.CrossRef
29.
go back to reference Alam S, Elwyn G, Percac-Lima S, Grande S, Durand MA. Assessing the acceptability and feasibility of encounter decision aids for early stage breast cancer targeted at underserved patients. BMC Med Inform Decis Mak déc. 2016;16(1):147.CrossRef Alam S, Elwyn G, Percac-Lima S, Grande S, Durand MA. Assessing the acceptability and feasibility of encounter decision aids for early stage breast cancer targeted at underserved patients. BMC Med Inform Decis Mak déc. 2016;16(1):147.CrossRef
30.
go back to reference Lumivero. NVivo [Internet]. Disponible sur: www.lumivero.com. Lumivero. NVivo [Internet]. Disponible sur: www.lumivero.com.
31.
go back to reference Santé Publique France. Communiquer pour tous_guide pour une information accessible. Santé Publique France. Communiquer pour tous_guide pour une information accessible.
32.
go back to reference Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 30 sept 2021;n2061. Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 30 sept 2021;n2061.
33.
go back to reference R Core Team. R: A Language and Environment for Statistical Computing. R Core Team. R: A Language and Environment for Statistical Computing.
34.
go back to reference Guest G, Bunce A, Johnson L. How many interviews are Enough? An experiment with data saturation and variability. Field Methods févr. 2006;18(1):59–82. Guest G, Bunce A, Johnson L. How many interviews are Enough? An experiment with data saturation and variability. Field Methods févr. 2006;18(1):59–82.
35.
go back to reference Scalia P, Durand MA, Faber M, Kremer JA, Song J, Elwyn G. User-testing an interactive option grid decision aid for prostate cancer screening: lessons to improve usability. BMJ Open Mai. 2019;9(5):e026748.CrossRef Scalia P, Durand MA, Faber M, Kremer JA, Song J, Elwyn G. User-testing an interactive option grid decision aid for prostate cancer screening: lessons to improve usability. BMJ Open Mai. 2019;9(5):e026748.CrossRef
37.
go back to reference Pornet C, Delpierre C, Dejardin O, Grosclaude P, Launay L, Guittet L, et al. Construction of an adaptable European transnational ecological deprivation index: the French version. J Epidemiol Community Health Nov. 2012;66(11):982–9.CrossRef Pornet C, Delpierre C, Dejardin O, Grosclaude P, Launay L, Guittet L, et al. Construction of an adaptable European transnational ecological deprivation index: the French version. J Epidemiol Community Health Nov. 2012;66(11):982–9.CrossRef
38.
go back to reference Durand MA, Lamouroux A, Redmond NM, Rotily M, Bourmaud A, Schott AM, et al. Impact of a health literacy intervention combining general practitioner training and a consumer facing intervention to improve colorectal cancer screening in underserved areas: protocol for a multicentric cluster randomized controlled trial. BMC Public Health déc. 2021;21(1):1684.CrossRef Durand MA, Lamouroux A, Redmond NM, Rotily M, Bourmaud A, Schott AM, et al. Impact of a health literacy intervention combining general practitioner training and a consumer facing intervention to improve colorectal cancer screening in underserved areas: protocol for a multicentric cluster randomized controlled trial. BMC Public Health déc. 2021;21(1):1684.CrossRef
39.
go back to reference Berger E, Delpierre C, Despas F, Bertoli S, Bérard E, Bombarde O, et al. Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients. BMC Cancer déc. 2019;19(1):883.CrossRef Berger E, Delpierre C, Despas F, Bertoli S, Bérard E, Bombarde O, et al. Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients. BMC Cancer déc. 2019;19(1):883.CrossRef
40.
go back to reference Bryere J, Dejardin O, Bouvier V, Colonna M, Guizard AV, Troussard X, et al. Socioeconomic environment and cancer incidence: a French population-based study in Normandy. BMC Cancer déc. 2014;14(1):87.CrossRef Bryere J, Dejardin O, Bouvier V, Colonna M, Guizard AV, Troussard X, et al. Socioeconomic environment and cancer incidence: a French population-based study in Normandy. BMC Cancer déc. 2014;14(1):87.CrossRef
Metadata
Title
Increasing access to fertility preservation for women with breast cancer: protocol for a stepped-wedge cluster randomized trial in France
Authors
Maria Claudia Addamiano
Camille Joannes
Leslie Fonquerne
Charlotte Morel
Delphine Lauzeille
Lorène Belkadi
Fabienne Empereur
Pascale Grosclaude
Eric Bauvin
Cyrille Delpierre
Sébastien Lamy
Marie-Anne Durand
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-17719-3

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue